ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1032

Epidemiology and Geographic Evaluation of ANCA-associated Vasculitis (AAV) at a Rural Academic Health Center Utilizing an Electronic Health Record (EHR)

Eva Rottmann1, Jason Bankert2, Andrea Berger2, Lester Kirchner2, Joseph Dewalle2, Marissa Meissner3, Jason George2, Ion Dan Bucaloiu2, Jaya Prakash Sugunaraj2, Sudheer Penupolu2 and David Bulbin1, 1Geisinger Health System, Danville, PA, 2Geisinger Medical Center, Danville, PA, 3Geisinger Medical Center, Danville

Meeting: ACR Convergence 2020

Keywords: ANCA associated vasculitis, Eosinophilic Granulomatosus with Polyangiitis (Churg-Strauss), Epidemiology, Granulomatosis with Polyangiitis (GPA), Microscopic Polyangiitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Epidemiology & Public Health Poster III: Inflammatory Rheumatic Disease

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: ANCA-associated vasculitis has a reported prevalence ranging from 3.2 to 9.1 cases per 100,000 individuals, but little is known of geographic variations. The aim of this study is to observe the prevalence of AAV in a rural based health system using updated ACR/EULAR Diagnostic and Classification Criteria for Primary Systemic Vasculitis (DCVAS). The study also provides geographic mapping of cases to investigate potential environmental factors. 

Methods: We reviewed patients with potential AAV through use of EHR from 1/1/2003-6/30/2018 with ICD 9/10 codes consistent with AAV, granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), or eosinophilic granulomatosis with polyangiitis (EGPA). We conducted a manual chart review of cases that satisfy ACR/EULAR DCVAS.  Each case was independently confirmed by a rheumatologist, pulmonologist and nephrologist. The denominator for a 5-year point prevalence estimate was calculated by identifying patients > 18 years old with a PCP encounter between 1/1/2003-6/30/2018 who had at least one outpatient encounter between 1/1/2014-12/31/2018. The numerator was calculated by identifying AAV cases within the denominator population. The prevalence estimate was calculated using a simple binomial proportion and the simple asymptotic continuity corrected 95% confidence interval. Prevalence estimates for GPA, MPA, and EGPA were calculated using similar methods as for overall AAV prevalence.  Because of the rarity, the 95% confidence interval for the EGPA is reported using a Clopper-Pearson exact method.  Statistical analysis was completed using SAS 9.4. All confirmed cases of AAV were plotted along a map to evaluate geographic distribution.

Results: Out of 2983 cases screened by ICD codes, 108 cases satisfied DCVAS. For prevalence criteria, there were 54 confirmed cases out of a denominator population of 458,588. The prevalence estimate for AAV is 11.6/ 100,000 (95% CI: 8.4, 14.8). The total population mean age was 50.7, 55.0% were female and 93.9% were Caucasian. Among the 54 AAV patients, the mean age was 60.8, 50.0% were female, and 96.3% were Caucasian.  There were 38 patients with GPA, 13 with MPA, and 3 with EGPA. Prevalence estimates and demographic characteristics are shown in Figure 1 and Figure 2. The prevalence estimates for AAV and GPA is observed to be above the reported national average range.  Our geographic mapping shows correlation of cases in counties deemed as Coal Region, following along a major interstate, a regional river, and primary medical service area (Figure 3).

Conclusion: Our prevalence estimates for AAV and GPA is observed to be higher than average, but MPA and EGPA has insufficient U.S. epidemiology to compare. Our health system captures a large region of predominantly Caucasian patients in a rural population so it is of interest to compare to national averages. Mapping suggests a correlation of AAV cases in Coal Region counties and along a major river, suggesting a possible environmental factor. We hope to explore potential environmental-gene interactions and compare epidemiology with an urban system in the future


Disclosure: E. Rottmann, None; J. Bankert, None; A. Berger, None; L. Kirchner, None; J. Dewalle, None; M. Meissner, None; J. George, None; I. Bucaloiu, None; J. Sugunaraj, None; S. Penupolu, None; D. Bulbin, Novartis, 5, 8, Alexion, 8.

To cite this abstract in AMA style:

Rottmann E, Bankert J, Berger A, Kirchner L, Dewalle J, Meissner M, George J, Bucaloiu I, Sugunaraj J, Penupolu S, Bulbin D. Epidemiology and Geographic Evaluation of ANCA-associated Vasculitis (AAV) at a Rural Academic Health Center Utilizing an Electronic Health Record (EHR) [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/epidemiology-and-geographic-evaluation-of-anca-associated-vasculitis-aav-at-a-rural-academic-health-center-utilizing-an-electronic-health-record-ehr/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epidemiology-and-geographic-evaluation-of-anca-associated-vasculitis-aav-at-a-rural-academic-health-center-utilizing-an-electronic-health-record-ehr/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology